Bank Of Montreal Has Raised Monmouth Real Estate Invt Co (MNR) Holding; 4 Analysts Are Bullish Motif Bio plc (LON:MTFB) Last Week

June 6, 2018 - By Dolores Ford

Among 4 analysts covering Motif Bio Plc (LON:MTFB), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Motif Bio Plc had 98 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Monday, November 21 by Northland Capital. The rating was maintained by Northland Capital with “Buy” on Wednesday, January 6. The stock of Motif Bio plc (LON:MTFB) has “Buy” rating given on Wednesday, July 13 by Northland Capital. The rating was maintained by FinnCap with “Buy” on Tuesday, May 30. The firm has “Buy” rating by Northland Capital given on Tuesday, November 24. The company was maintained on Wednesday, October 4 by Northland Capital. The company was maintained on Thursday, November 12 by Beaufort Securities. Northland Capital maintained the shares of MTFB in report on Thursday, September 8 with “Buy” rating. The firm earned “Buy” rating on Monday, August 24 by Northland Capital. The company was maintained on Wednesday, April 19 by Beaufort Securities. See Motif Bio plc (LON:MTFB) latest ratings:

31/05/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 102.00 Maintain
23/05/2018 Broker: Northland Capital Rating: Buy Old Target: GBX 115.00 Maintain
18/05/2018 Broker: Northland Capital Rating: Buy Old Target: GBX 115.00 Maintain
08/05/2018 Broker: Northland Capital Rating: Buy New Target: GBX 115.00 Maintain
04/05/2018 Broker: Northland Capital Rating: Buy Old Target: GBX 115.00 New Target: GBX 115.00 Maintain
01/05/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 102.00 Maintain
13/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 106.00 New Target: GBX 102.00 Maintain
10/04/2018 Broker: Northland Capital Rating: Buy Maintain
10/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 106.00 New Target: GBX 106.00 Maintain
03/04/2018 Broker: Northland Capital Rating: Buy Maintain

Bank Of Montreal increased Monmouth Real Estate Invt Co (MNR) stake by 233.08% reported in 2018Q1 SEC filing. Bank Of Montreal acquired 40,367 shares as Monmouth Real Estate Invt Co (MNR)’s stock rose 6.90%. The Bank Of Montreal holds 57,686 shares with $868,000 value, up from 17,319 last quarter. Monmouth Real Estate Invt Co now has $1.24B valuation. The stock decreased 0.13% or $0.02 during the last trading session, reaching $15.61. About 220,198 shares traded. Monmouth Real Estate Investment Corporation (NYSE:MNR) has risen 3.61% since June 6, 2017 and is uptrending. It has underperformed by 8.96% the S&P500. Some Historical MNR News: ; 06/04/2018 – MONMOUTH REAL ESTATE INVESTMENT CORP – DEAL FOR $30.75 MLN; 20/04/2018 – DJ Monmouth Real Estate Investment Cor, Inst Holders, 1Q 2018 (MNR); 08/05/2018 – MONMOUTH REAL ESTATE INVESTMENT CORP QTRLY AFFO PER DILUTED COMMON SHARE $0.22; 23/05/2018 – Report: Developing Opportunities within MFA Financial, Stewart Information Services, Eagle Bulk Shipping, Monmouth Real Estate; 15/05/2018 – One of the first sports betting operations to open outside Nevada could be at Monmouth Park racetrack in New Jersey; 02/04/2018 – Monmouth Real Estate Declares Common and Preferred Dividends; 30/05/2018 – Monmouth Real Estate to Participate in NAREIT’s REITweek: 2018 Investor Conference; 30/05/2018 – Monmouth Real Estate to Participate in NAREIT’s RElTweek: 2018 Investor Conference; 08/05/2018 – Monmouth Real Estate 2Q EPS 10c; 06/03/2018 Monmouth Real Estate at Company Marketing Hosted By FBR Today

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company has market cap of 94.15 million GBP. The firm develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. It currently has negative earnings. The Company’s lead product candidate is Iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus.

The stock decreased 2.31% or GBX 0.7498 during the last trading session, reaching GBX 31.7502. About 20,004 shares traded. Motif Bio plc (LON:MTFB) has 0.00% since June 6, 2017 and is . It has underperformed by 12.57% the S&P500. Some Historical MTFB News: ; 09/05/2018 – Motif Bio Appoints Vice President for Clinical Development; 19/04/2018 – Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease; 03/05/2018 – Motif Bio Non-Deal Roadshow Scheduled By Northland for May. 10; 03/04/2018 – MOTIF BIO INITIATES NDA ROLLING SUBMISSION FOR ICLAPRIM AND PROVIDES BUSINESS UPDATE; 27/03/2018 – The Next Frontier: Motif Introduces Artificial Intelligence Portfolio; 09/05/2018 – Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President, Clinical Development; 20/03/2018 – MOTIF BIO PLC MTFB.L – CO HAS DECIDED THAT IN ORDER TO ENSURE A COMPLETE AND HIGH QUALITY SUBMISSION, IT WOULD BE PRUDENT TO TAKE ADDITIONAL TIME; 03/04/2018 – Motif Bio Starts Fast-Track Application for Iclaprim; 10/04/2018 – MOTIF BIO PLC MTFB.L – DEBT FINANCING OF $20 MLN SUCCESSFULLY COMPLETED; $15 MLN HAS BEEN DRAWN DOWN; 09/05/2018 – Motif Bio at Non-Deal Roadshow Hosted By Northland Today

Investors sentiment increased to 1.93 in Q1 2018. Its up 0.54, from 1.39 in 2017Q4. It improved, as 15 investors sold MNR shares while 40 reduced holdings. 32 funds opened positions while 74 raised stakes. 51.26 million shares or 2.04% more from 50.24 million shares in 2017Q4 were reported. Neville Rodie Shaw invested in 0.17% or 100,000 shares. 76,297 were reported by Price T Rowe Assoc Inc Md. Oppenheimer Company has 35,929 shares. Invesco Limited has 0% invested in Monmouth Real Estate Investment Corporation (NYSE:MNR) for 61,696 shares. Whittier stated it has 0% in Monmouth Real Estate Investment Corporation (NYSE:MNR). Envestnet Asset Mgmt Inc accumulated 9,488 shares. Sei accumulated 9,133 shares. Stifel Finance Corporation has invested 0% of its portfolio in Monmouth Real Estate Investment Corporation (NYSE:MNR). Creative Planning holds 0% or 22,210 shares. Ubs Asset Management Americas invested in 198,630 shares. Ronna Sue Cohen accumulated 144,216 shares or 1.61% of the stock. Principal holds 0.01% or 682,937 shares in its portfolio. Point72 Asia (Hong Kong) Ltd accumulated 1,870 shares or 0.01% of the stock. Citadel Lc holds 166,236 shares. Bank Of Mellon Corporation reported 727,749 shares stake.

Among 7 analysts covering Monmouth Real Estate Investment Corporation (NYSE:MNR), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Monmouth Real Estate Investment Corporation has $20.0 highest and $11.50 lowest target. $17.20’s average target is 10.19% above currents $15.61 stock price. Monmouth Real Estate Investment Corporation had 16 analyst reports since August 10, 2015 according to SRatingsIntel. DA Davidson maintained it with “Neutral” rating and $16 target in Thursday, December 1 report. As per Friday, December 2, the company rating was downgraded by BMO Capital Markets. The firm has “Buy” rating by DA Davidson given on Thursday, May 18. B. Riley & Co downgraded the stock to “Neutral” rating in Friday, February 9 report. The firm earned “Outperform” rating on Monday, August 24 by BMO Capital Markets. The stock of Monmouth Real Estate Investment Corporation (NYSE:MNR) earned “Hold” rating by FBR Capital on Friday, February 9. The stock of Monmouth Real Estate Investment Corporation (NYSE:MNR) has “Buy” rating given on Friday, May 5 by National Securities. The rating was maintained by BMO Capital Markets on Tuesday, January 9 with “Hold”. Wunderlich maintained Monmouth Real Estate Investment Corporation (NYSE:MNR) rating on Friday, May 6. Wunderlich has “Buy” rating and $13 target. The firm has “Buy” rating given on Monday, August 10 by Wunderlich.

Bank Of Montreal decreased Vanguard Index Fds (VTI) stake by 24,154 shares to 805,899 valued at $109.38M in 2018Q1. It also reduced Willis Towers Watson Pub Ltd stake by 109,996 shares and now owns 162,946 shares. Gallagher Arthur J & Co (NYSE:AJG) was reduced too.

More news for Monmouth Real Estate Investment Corporation (NYSE:MNR) were recently published by: Seekingalpha.com, which released: “Monmouth: Slow To Recover” on May 30, 2018. Globenewswire.com‘s article titled: “Report: Developing Opportunities within MFA Financial, Stewart Information Services, Eagle Bulk Shipping, Monmouth …” and published on May 23, 2018 is yet another important article.

Since December 18, 2017, it had 11 insider purchases, and 1 sale for $242,959 activity. Miller Kevin S. had bought 68 shares worth $1,006. Shares for $1,998 were bought by LANDY MICHAEL P on Tuesday, May 15. $49,739 worth of Monmouth Real Estate Investment Corporation (NYSE:MNR) was bought by Elflein Catherine B.. $24,057 worth of Monmouth Real Estate Investment Corporation (NYSE:MNR) was sold by WOLGIN STEVEN B. LANDY EUGENE W bought $10,005 worth of stock or 676 shares. The insider UMH PROPERTIES – INC. bought 10,891 shares worth $153,999.

Monmouth Real Estate Investment Corporation (NYSE:MNR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>